Patent Assignment
Reel/Frame 051585/0806
Change of Name
Recorded: 2020-01-14
Pages: 8
Assignor
SHIRE VIROPHARMA INCORPORATED
Executed: 2019-12-20
Assignee
SHIRE VIROPHARMA LLC
300 SHIRE WAY, LEXINGTON, MASSACHUSETTS, 02421
Covered Properties
(14)
C1-Inh Compositions and Methods for the Prevention and Treatment of Disorders Associated with C1 Esterase Inhibitor Deficency
PCT:
PCT/US2014/030309 ↗
Compositions and Methods Useful for the Treatment of Neuromyelitis Optica Spectrum Disorders
Patent:
10,272,142 →
Application:
14/539,405 →
Publication:
US 2015/0132296
PCT:
PCT/US2014/065180 ↗
C1-Inh Compositions and Methods for the Prevention and Treatment of Disorders Associated with C1 Esterase Inhibitor Deficiency
C1-Inh Compositions and Methods for the Prevention and Treatment of Disorders Associated with C1 Esterase Inhibitor Deficiency
Application:
15/411,744 →
Publication:
US 2017/0224788
C1-Inh Compositions and Methods for the Prevention and Treatment of Disorders Associated with C1 Esterase Inhibitor Deficiency
C1-Inh Compositions and Methods for the Prevention and Treatment of Disorders Associated with C1 Esterase Inhibitor Deficiency
C1-Inh Compositions and Methods for the Prevention and Treatment of Disorders Associated with C1 Esterase Inhibitor Deficiency
C1-Inh Compositions and Methods for the Prevention and Treatment of Disorders Associated with C1 Esterase Inhibitor Deficiency
C1-Inh Compositions and Methods for the Prevention and Treatment of Disorders Associated with C1 Esterase Inhibitor Deficiency
C1-Inh Compositions and Methods for the Prevention and Treatment of Disorders Associated with C1 Esterase Inhibitor Deficiency
Application:
16/122,015 →
Publication:
US 2019/0160158
Compositions and Methods Useful for the Treatment of Neuromyelitis Optica Spectrum Disorders
C1-Inh Compositions and Methods for the Prevention and Treatment of Disorders Associated with C1 Esterase Inhibitor Deficiency
C1-Inh Compositions and Methods for the Prevention and Treatment of Disorders Associated with C1 Esterase Inhibitor Deficency
Application:
61/791,399 →
Compositions and Methods Useful for the Treatment of Neuromyelitis Optica Spectrum Disorders
Application:
61/903,643 →
Related Assignments
(13)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 10, 2014
From: BROOM, COLIN; DAYNO, JEFFREY
To: VIROPHARMA HOLDINGS LIMITED
Reel/Frame 034132/0515 →
Assignment of Assignor's Interest
Jul 17, 2015
From: BROOM, COLIN; DAYNO, JEFFREY
To: VIROPHARMA HOLDINGS LIMITED
Reel/Frame 036122/0249 →
Assignment of Assignor's Interest
Jul 17, 2015
From: DUOCORT PHARMA AB; VIROPHARMA HOLDINGS LIMITED
To: SHIRE VIROPHARMA INCORPORATED
Reel/Frame 036122/0241 →
Assignment of Assignor's Interest
May 11, 2016
From: RUDDY, STEPHEN; MANNING, MARK CORNELL; HOLCOMB, RYAN
To: SHIRE VIROPHARMA INCORPORATED
Reel/Frame 038548/0632 →
Assignment of Assignor's Interest
Apr 26, 2017
From: RUDDY, STEPHEN; MANNING, MARK CORNELL; HOLCOMB, RYAN
To: SHIRE VIROPHARMA INCORPORATED
Reel/Frame 042149/0950 →
Assignment of Assignor's Interest
Jul 31, 2018
From: RUDDY, STEPHEN; MANNING, MARK CORNELL; HOLCOMB, RYAN
To: SHIRE VIROPHARMA INCORPORATED
Reel/Frame 046507/0177 →
Assignment of Assignor's Interest
May 9, 2019
From: RUDDY, STEPHEN; MANNING, MARK CORNELL; HOLCOMB, RYAN
To: SHIRE VIROPHARMA INCORPORATED
Reel/Frame 049124/0659 →
Assignment of Assignor's Interest
May 10, 2019
From: DUOCORT PHARMA AB; VIROPHARMA HOLDINGS LIMITED
To: SHIRE VIROPHARMA INCORPORATED
Reel/Frame 049141/0806 →
Assignment of Assignor's Interest
May 10, 2019
From: BROOM, COLIN; DAYNO, JEFFREY
To: VIROPHARMA HOLDINGS LIMITED
Reel/Frame 049141/0798 →
Assignment of Assignor's Interest
Mar 25, 2020
From: RUDDY, STEPHEN; MANNING, MARK CORNELL; HOLCOMB, RYAN
To: SHIRE VIROPHARMA INCORPORATED
Reel/Frame 052220/0755 →
Assignment of Assignor's Interest
May 20, 2021
From: SHIRE VIROPHARMA LLC
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 056307/0254 →
Assignment of Assignor's Interest
Jul 7, 2021
From: BROOM, COLIN; DAYNO, JEFFREY
To: VIROPHARMA HOLDINGS LIMITED
Reel/Frame 056781/0490 →
Merger
Jul 15, 2021
From: SHIRE VIROPHARMA LLC
To: VIROPHARMA BIOLOGICS LLC
Reel/Frame 056870/0151 →